Altogether, these results indicate that our genetic approach efficiently reduces the C9orf72 protein levels in vivo, and this C9-miR line can be used to understand the role of C9orf72 haploinsufficiency in ALS. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.